Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cardiotoxicity × Ramipril × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Cardiotoxicity 1 Breast Neoplasms 1

Interventions

Trastuzumab 6 Exercise 6 Doxorubicin 6 Echocardiography 4 Cyclophosphamide 4 Carvedilol 4 Docetaxel 3 Tablets 2 Magnetic Resonance Spectroscopy 2 Bisoprolol 2 Atorvastatin 2 Anthracyclines 2 sacubitril and valsartan sodium hydrate drug combination 1 nicotinamide-beta-riboside 1 mitoquinone 1 epicatechin gallate 1 empagliflozin 1 dapagliflozin 1 candesartan 1 Watchful Waiting 1 Therapeutics 1 Social Determinants of Health 1 Silymarin 1 Secondary Prevention 1 Rosuvastatin Calcium 1 Reverse Transcriptase Polymerase Chain Reaction 1 Restraint, Physical 1 Rehabilitation 1 Ramipril 1 Radiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02236806 2022-02-01

SAFE

Azienda Ospedaliero-Universitaria Careggi

Phase 3 Unknown

Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡